XML 62 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Additional Information (Detail)
3 Months Ended 12 Months Ended
Sep. 30, 2019
USD ($)
Dec. 31, 2020
USD ($)
Segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Number of operating segment | Segment   1      
Cash, cash equivalents and marketable securities   $ 165,000,000.0      
Inventory reserves   0 $ 0 $ 1,000,000.0  
Impairment of Intangible assets   0 0 $ 0  
Accelerated depreciation related to certain long-lived assets $ 3,000,000.0   3,000,000.0    
Goodwill impairment   $ 0 $ 0   $ 0
Credit Concentration Risk          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Concentration risk, customer   three largest customers three largest customers three largest customers  
Trade Receivable | Credit Concentration Risk          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Concentration risk, percentage   86.00% 76.00%    
Product | Revenue | Credit Concentration Risk          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Concentration risk, percentage   61.00% 62.00% 68.00%  
HEPLISAV-B          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Increase in product revenue   $ 800,000      
United States          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Percentage of revenue earned   77.00% 100.00% 83.00%  
Percentage of long lived assets   57.00% 62.00%    
Maximum          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Cash equivalents original maturity period   3 months      
Expected period of payment to be received   1 year      
Dynavax GmbH          
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]          
Cumulative translation adjustment   $ 200 $ (2,500)    
Currency translation adjustments   2,700,000 (500,000) $ (1,100,000)  
Currency transaction gain (loss)   $ (800,000) $ 200,000 $ 300,000